Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS-containing triple therapy versus non-ICS dual bronchodilator therapy for cardiovascular vascular aging markers in COPD
ISRCTN11747857Phase 4Terminated
- Sponsor
- Imperial College London
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial in chronic obstructive pulmonary disease (COPD) comparing Trixeo Aerosphere arm with Bevespi Aerosphere arm (2 arms). Primary endpoint: Degree of senescence in endothelial progenitors. Started Feb 2025; status: terminated.
02
Drugs
budesonideBEVESPI AEROSPHERE
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ISRCTN11747857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11747857.